The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2.

Citation data:

American heart journal, ISSN: 0002-8703, Vol: 141, Issue: 6, Page: 933-9

Publication Year:
2001
Usage 262
Abstract Views 261
Link-outs 1
Captures 23
Readers 21
Exports-Saves 2
Citations 245
Citation Indexes 241
Clinical Citations 4
Repository URL:
https://escholarship.umassmed.edu/qhs_pp/291; https://works.bepress.com/robert_goldberg/210
PMID:
11376306
DOI:
10.1067/mhj.2001.115295
Author(s):
Barron, H V; Every, N R; Parsons, L S; Angeja, B; Goldberg, R J; Gore, J M; Chou, T M; Investigators in the National Registry of Myocardial Infarction 2
Publisher(s):
Elsevier BV
Tags:
Medicine; Aged; Angioplasty; Cohort Studies; Female; Humans; Intra-Aortic Balloon Pumping; Male; Myocardial Infarction; Registries; Retrospective Studies; Shock, Cardiogenic; Thrombolytic Therapy; United States; Bioinformatics; Biostatistics; Epidemiology; Health Services Research
article description
Cardiogenic shock complicating acute myocardial infarction (AMI) remains the leading cause of death in patients hospitalized with AMI. Although several studies have demonstrated the importance of establishing and maintaining a patent infarct-related artery, it remains unclear as to whether intra-aortic balloon counterpulsation (IABP) provides incremental benefit to reperfusion therapy. The purpose of this study was to determine whether IABP use is associated with lower in-hospital mortality rates in patients with AMI complicated by cardiogenic shock in a large AMI registry.